These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 6718438

  • 21. [Characterization of storage-induced release reductions in suppositories (author's transl)].
    Voigt R, Grohmann A, Bornschein M.
    Pharmazie; 1981 Sep; 36(9):631-3. PubMed ID: 7301905
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of aminophylline suppositories prepared in a hospital pharmacy.
    Fujii T, Kubota A, Togawa K, Mizushima N.
    Tokai J Exp Clin Med; 1982 May; 7(3):371-83. PubMed ID: 7123575
    [Abstract] [Full Text] [Related]

  • 23. Enhanced absorption of phenobarbital from suppositories containing amino acid and choline salts of phenobarbital.
    Iwaoku R, Nakano M.
    Chem Pharm Bull (Tokyo); 1987 Nov; 35(11):4645-9. PubMed ID: 3442899
    [No Abstract] [Full Text] [Related]

  • 24. [Assay of a method of analysis for complex excipients used in pomades and suppositories. I. Analysis of excipients with glyceride bases using a thin-layer chromatographic method].
    Febvre P, Aiache JM.
    Ann Pharm Fr; 1968 Jun; 26(6):463-8. PubMed ID: 5714136
    [No Abstract] [Full Text] [Related]

  • 25. Investigation of hypoglycemic properties of rectal suppositories with chlorpropamide.
    Kosior A.
    Acta Pol Pharm; 2002 Jun; 59(2):109-13. PubMed ID: 12365601
    [Abstract] [Full Text] [Related]

  • 26. The drug release characteristics of various rectal suppositories as determined by specific ion electrodes.
    Thomas WH, McCormack R.
    J Pharm Pharmacol; 1971 Jul; 23(7):490-4. PubMed ID: 4397446
    [No Abstract] [Full Text] [Related]

  • 27. Enhanced absorption of phenobarbital from suppositories containing phenobarbital povidone coprecipitate.
    Iwaoku R, Okamatsu Y, Kino S, Arimori K, Nakano M.
    Chem Pharm Bull (Tokyo); 1984 Mar; 32(3):1091-5. PubMed ID: 6744481
    [No Abstract] [Full Text] [Related]

  • 28. [A comparative pharmacokinetic study for tablet and suppository formulations of a combination product of caffeine, ethaverine, propyphenazone, paracetamol and phenobarbital (author's transl)].
    Maier-Lenz H, Ringwelski L, Windorfer A.
    Arzneimittelforschung; 1981 Mar; 31(1):105-9. PubMed ID: 7194086
    [Abstract] [Full Text] [Related]

  • 29. [Availability of phenobarbital from suppository form (author's transl)].
    Puech A, Lasserre Y, Jacob M, Duru C.
    J Pharm Belg; 1981 Mar; 36(5):332-6. PubMed ID: 7310627
    [No Abstract] [Full Text] [Related]

  • 30. Effect of suppository bases on the release properties of a potent antimicrobial agent (C31G).
    Caliş S, Sumnu M, Hincal AA.
    Pharmazie; 1994 May; 49(5):336-9. PubMed ID: 8016179
    [Abstract] [Full Text] [Related]

  • 31. [Analysis method of complex excipients for ointments and suppositories. II. Analysis of a complex mixture with glyceride base].
    Aiache JM, Aiache S, Febvre P.
    Ann Pharm Fr; 1969 May; 27(9):575-80. PubMed ID: 5368593
    [No Abstract] [Full Text] [Related]

  • 32. Dissolution and vaginal absorption characteristics of metronidazole and ornidazole.
    Ozyazici M, Gökçe E, Hizarcioglu SY, Taner MS, Köseoglu K, Ertan G.
    Pharmazie; 2006 Oct; 61(10):855-61. PubMed ID: 17069425
    [Abstract] [Full Text] [Related]

  • 33. [The determination of the real dissolution rate of drug substances in melted suppository masses].
    Schöbel H, Klaus T, Raguse U, Pflegel P.
    Pharmazie; 1988 Sep; 43(9):650-1. PubMed ID: 3244737
    [No Abstract] [Full Text] [Related]

  • 34. [Biopharmaceutical evaluation of the intrarectal use of mefenamic acid. III. Effect of solubilizers on the biological availability of mefenamic acid from witepsol H15].
    Kosior A.
    Acta Pol Pharm; 1986 Sep; 43(2):156-60. PubMed ID: 3776655
    [No Abstract] [Full Text] [Related]

  • 35. Effect of drug solubility on in vitro availability rate from suppositories with polyethylene glycol excipients.
    Realdon N, Ragazzi E, Ragazzi E.
    Pharmazie; 2001 Feb; 56(2):163-7. PubMed ID: 11234347
    [Abstract] [Full Text] [Related]

  • 36. Effects of surfactant characteristics on drug availability from suppositories.
    Realdon N, Dal Zotto M, Morpurgo M, Franceschinis E.
    Pharmazie; 2008 Jun; 63(6):459-63. PubMed ID: 18604990
    [Abstract] [Full Text] [Related]

  • 37. [SEMI-SYNTHETIC glycerides,vehicles for suppositories].
    Ann Pharm Fr; 1960 Apr; 18():258-60. PubMed ID: 13856632
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Physicopharmaceutical characteristics of ulinastatin vaginal suppositories prepared in a hospital].
    Satake K, Nakajima T, Iwata M, Fujikake Y, Kimura M.
    Yakugaku Zasshi; 2011 Apr; 131(11):1639-44. PubMed ID: 22041703
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics and relative bioavailability of intramuscular phenobarbital sodium or acid in infants.
    Minagawa K, Miura H, Chiba K, Ishizaki T.
    Pediatr Pharmacol (New York); 1981 Apr; 1(4):279-89. PubMed ID: 7346748
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.